What top creators are saying about Arcutis Biotherapeutics, Inc.(ARQT)

Biopharmaceutical company developing treatments for dermatological diseases.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Arcutis Biotherapeutics, Inc..

Mixed
avg +0.00
0 bullish1 neutral0 bearish

Top creators covering Arcutis Biotherapeutics, Inc. (ARQT)

The 1 sources with the most insights about Arcutis Biotherapeutics, Inc. on Kazuha.

@realmartinshkreli
@realmartinshkreli
YouTube·1 insight

Latest insights about Arcutis Biotherapeutics, Inc. (ARQT)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Neutral

Mentioned among biotech fund holdings; no company-specific investment analysis was provided.

Martin Shkreli
11/9/26 - wassup fellow spy
Martin ShkreliYouTube1 hour ago

Discussed alongside Arcutis Biotherapeutics, Inc. (ARQT)

Other assets that creators frequently mention in the same content as Arcutis Biotherapeutics, Inc..

BHVNBiohaven Ltd.1×SFTBYSoftBank Group Corp.1×LEGNLegend Biotech Corporation1×CGONCG Oncology, Inc.1×ERASErasca, Inc.1×SLSSELLAS Life Sciences Group, Inc.1×

Frequently asked

Which podcasters and creators cover Arcutis Biotherapeutics, Inc. (ARQT) the most?

The most active sources covering Arcutis Biotherapeutics, Inc. (ARQT) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Arcutis Biotherapeutics, Inc. (ARQT) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Arcutis Biotherapeutics, Inc. (ARQT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Arcutis Biotherapeutics, Inc. (ARQT)?

Creators covering Arcutis Biotherapeutics, Inc. (ARQT) most frequently also discuss BHVN, SFTBY, LEGN, CGON, ERAS. See the "Discussed alongside" section above for full asset pages.